Substance Use Tools & Resources  

Read the Guide

A collection of tools and resources for providers, staff, and patients who offer or use services to address substance use. See the full environmental scan (PDF 0.69 MB) and resources collection (PDF 1.28 MB) in PDF format.

Displaying 81 - 90 of 616

Polysubstance Use Disorders in Four State Medicaid Programs

This brief examines the prevalence of diagnoses of polysubstance use disorders, describes the characteristics of Medicaid enrollees with polysubstance use disorders, and compares the mental health and medical comorbidities based on the number of unique substance use disorders.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Academy Health
Year
Resource Type
PDF

Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder

These guidelines provide eligible clinicians who are state licensed and registered by the DEA to prescribe controlled substances, an exemption from certain statutory certification requirements related to training, counseling and other ancillary services.
Format
Other
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Department of Health and Human Services (HHS)
Year
Resource Type
PDF

Reimbursement for Medications for Addiction Treatment Toolkit

This guide provides considerations and strategies for clinicians and organizations implementing evidence-based practices. Approaches presented will assist clinicians, behavioral health organizations, primary care providers, insurers, and policy makers in understanding, selecting, and implementing evidence-based interventions that support adults with concurrent substance use and/or concurrent substance use disorders, including alcohol.

Format
Toolkit
Audience
Behavioral Health Providers
Medical Providers
Other Team Members
Policymakers
States
Source
Providers Clinical Support System (PCSS)
Year
Resource Type
PDF

Safe Use of Benzodiazepines: Clinical, Regulatory, and Public Health Perspectives

This two-day public workshop convened regulators, academic researchers, clinicians, patient advocates, and other stakeholders to share information underlying this action and gather input related to the safe use of benzodiazepines.
Format
Webinar/Video
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Communities
Policymakers
Source
Duke-Margolis Center for Health Policy / Food and Drug Administration (FDA)
Year
Resource Type
Video